Wall Street welcomed three life science companies to the public markets this week. 10x Genomics led the way Wednesday, followed by SpringWorks Therapeutics and Satsuma Pharmaceuticals on Thursday. Combined, the three companies raised more than $595 million from their IPOs.
According to IPO research firm Renaissance Capital, 153 IPOs have been filed to date in 2019, 48 in healthcare—more than any other sector. Here’s a look at the three life science companies that went public this week.
UNDERWRITERS AND PARTNERS